Science magazine has crowned GLP-1 drugs such as Ozempic and Wegovy as Breakthrough of the Year. In today's episode, we'll dive into whether these drugs can actually deliver on their promise and give doctors a genuinely effective option for treating patients suffering from obesity.

In other news, the controversial chat show Koffee With Karan is rolling in dough.    

The Signal Daily is produced in association with IVM.The episode was researched and written by Anup SemwalEdited by Venkat Ananth Produced by ManaswiniMastered and mixed by Manas and Nirvaan

See omnystudio.com/listener for privacy information.